Tuesday 27 April, 12.30pm - 2.00pm AEST Going back to basics: New pharmacological insights to reveal mechanisms that drive opioid efficacy or side- .. Read more effects. With ongoing challenges in clinical opioid use, basic research in pain and molecular pharmacology of opioids continues to be valuable for improving our understanding of opioid mechanisms of action. This session will discuss some of the signalling processes that drive opioid efficacy and poor safety profiles at the molecular and cellular level, with the goal of revealing new insights that may be of interest to basic researchers and clinical researchers alike. Speakers: A/Professor Peter Grace, University of Texas, USA Dr Daniel Poole, Monash Institute of Pharmaceutical Sciences, VIC Professor Macdonald Christie, University of Sydney, NSW Professor Paul Rolan, University of Adelaide, SA. Interestingly, however, during nitrous oxide anesthesia and the initial stages of ether and isoflurane anesthesia, analgesia can be produced independently of loss of consciousness. In fact, the classical description of stages of anesthesia described an analgesic stage, followed by an amnesia stage, during which a patient could speak to the anesthesiologist, but have no memory of the event. Only in the last stage was unconsciousness produced.
- [ Users who have shown interest for this Event ]
- + Add me as user
- Share your Experience